Organization | ASST Gaetano Pini-CTO

ASST Gaetano Pini-CTO Report issue

Academic/Hospital Phase 2 Phase 4

Founded: Milano Italy (1874)

Organization Overview

First Clinical Trial

2013

NCT01803360

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2016

Timeline

NOW

Now

Active Ingredients

Drugs in Phase 4 Trials (9)

buprenorphine (1 trial)

dexmedetomidine (precedex) (3 trials)

icodextrin (Extraneal) (1 trial)

ketorolac (acuvail) (2 trials)

levobupivacaine (chirocaine) (3 trials)

mepivacaine (carbocaine) (2 trials)

morphine (1 trial)

prilocaine (citanest) (1 trial)

ropivacaine (naropin) (4 trials)

Drugs in Phase 2 Trials (4)

levodopa (larodopa) (1 trial)

mucuna pruriens (1 trial)

neridronic acid (1 trial)

serazide (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Arthritis (Phase 4)

Hallux Valgus (Phase 4)

Osteoarthritis (Phase 2)

Osteoarthritis, Knee (Phase 2)

Parkinson Disease (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 7
# of Trial APIs: 13